1 | 2024 comments off on | | | | | | 13 | 2.90% |
2 | 2 2024 comments off | | | | | | 9 | 2.00% |
3 | august 2 2024 comments | | | | | | 8 | 1.78% |
4 | august 3 2024 comments | | | | | | 6 | 1.34% |
5 | jobs post a job | | | | | | | 3 | 0.67% |
6 | – bridgewater nj 08807 | | | | | | | 3 | 0.67% |
7 | 3 2024 comments off | | | | | | 3 | 0.67% |
8 | ny august 3 2024 | | | | | | | 3 | 0.67% |
9 | substance – rensselaer ny | | | | | | | 3 | 0.67% |
10 | – jersey city nj | | | | | | | 3 | 0.67% |
11 | bioinformatics – tarrytown ny | | | | | | | 3 | 0.67% |
12 | 4 2024 comments off | | | | | | 3 | 0.67% |
13 | august 4 2024 comments | | | | | | 3 | 0.67% |
14 | jersey city nj 07310 | | | | | | | 3 | 0.67% |
15 | drug substance – rensselaer | | | | | | | 3 | 0.67% |
16 | open central pennsylvania campus | | | | | | | 2 | 0.45% |
17 | announces closing of 35 | | | | | | | 2 | 0.45% |
18 | gig insurance group and | | | | | | | 2 | 0.45% |
19 | insurance group and gifford | | | | | | | 2 | 0.45% |
20 | associate scientist – bridgewater | | | | | | | 2 | 0.45% |
21 | group and gifford wells | | | | | | | 2 | 0.45% |
22 | fda approval for cell | | | | | | | 2 | 0.45% |
23 | offering of common stock | | | | | | | 2 | 0.45% |
24 | of 35 million public | | | | | | | 2 | 0.45% |
25 | closing of 35 million | | | | | | | 2 | 0.45% |
26 | king of prussia pa | | | | | | | 2 | 0.45% |
27 | upmc opens expanded emergency | | | | | | | 2 | 0.45% |
28 | of prussia pa 19406 | | | | | | | 2 | 0.45% |
29 | sales specialist i – | | | | | | | 2 | 0.45% |
30 | specialist i – lcms | | | | | | | 2 | 0.45% |
31 | i – lcms – | | | | | | | 2 | 0.45% |
32 | leaderassociate director of cell | | | | | | | 2 | 0.45% |
33 | director of cell based | | | | | | | 2 | 0.45% |
34 | lands fda approval for | | | | | | | 2 | 0.45% |
35 | scientist – bridgewater nj | | | | | | | 2 | 0.45% |
36 | for cell therapy to | | | | | | | 2 | 0.45% |
37 | opens expanded emergency department | | | | | | | 2 | 0.45% |
38 | to open central pennsylvania | | | | | | | 2 | 0.45% |
39 | internal leader as head | | | | | | | 2 | 0.45% |
40 | ceo quickly returns with | | | | | | | 2 | 0.45% |